Policy
-
How Genome Sequencing Can Broaden the Scope of Newborn Screening
Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
-
Two Value-Based Care Initiatives That Could Shift the Alternative Payment Model Landscape
The Centers for Medicare and Medicaid Services has announced two value-based care alternative payment models set to launch in July 2024, one focused on dementia and one on primary care.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
W-2 Employed Nurses Can Have Choice and Flexibility, Too
As the debate over worker misclassification rages, it’s important that healthcare professionals know the facts. Staffing agencies that designate their nurses as independent contractors avoid the costs of employment-related benefits like insurance, workers’ compensation, and overtime pay. These agencies also lack necessary clinical and professional oversight over their contractors, which increases the risk of substandard care.
-
What Mask Hesitancy in the U.S. Reveals About the Need for a True Hygiene Discipline
To improve public health outcomes, not only at the local and national level, but also globally, we need to invest in hygiene research and those who seek to solve hygiene-related issues.
-
BioPharma, Hospitals, Legal, Payers, Policy
Hospitals Have Concerns About CMS’ Proposed $9B Lump Sum Payment for Illegal 340B Cuts
CMS recently proposed a $9 billion lump sum payment to remedy illegal payment cuts for 340B drugs from 2018 to 2022. In general, hospital groups have reacted positively to the fact that 340B providers will receive lump sum payments but have expressed concern about CMS’ methods for maintaining budget neutrality with this plan.
-
CareEvolution Webinar Highlights Healthcare Data Management Evolution
Health tech experts explained the nuances of healthcare data management and ways in which patient data can be cleaned, converted, standardized and harmonized across systems
-
MedCity Influencers, Policy, Opinion
Growing Nephrology Nursing Workforce Crisis Demands Policy Attention
It is critical for policymakers to work with nephology RNs to increase federal resources that will enable us to address burnout, decrease turnover rates, and build and support a stronger healthcare workforce nationwide.
-
MedCity Influencers, BioPharma, Legal
Biden’s New Executive Order Could Usher in an Era of Fair and Equitable Drug Pricing
By leveraging its large membership, Medicare could by embracing value-based contracting significantly influence the pharmaceutical market, pitting competing drugs against each other, or encouraging pharmaceutical makers to figure out ways to deliver drugs more cheaply.
-
MedCity Influencers, Policy, Payers
Could value-based care be more than its shortcomings?
Value-based care has provided a platform and a mechanism, where for the first time, health plans, providers and employer groups are sitting around the table with their sleeves rolled up, ready to collaborate and partner as opposed to sitting across the table with their arms crossed and their heels dug in.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
3 ways to reform the pharmacy benefits industry
At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.
-
Conservative majority on Supreme Court, as expected, end nationwide right to abortion
The decision about whether to allow the procedure now falls to individual state governments, and only 16, plus the District of Columbia, have passed laws to preserve the option, while two others have state constitutional protections that have been cited by state courts as protections for abortion.
-
BioPharma, Pharma, Policy, Social Determinants, SYN
Drug-industry survey blames insurer practices for barriers to care
Pharma companies often take the blame for high prescription costs. But a new, industry-sponsored survey shifts attention to insurance industry practices.
-
Aneesh Chopra: Greater ACO enrollment will bolster preventive care
The Biden administration aims to have all Medicare beneficiaries enrolled in alternative payment models by 2030. Aneesh Chopra, the federal government’s first-ever chief technology officer and currently president of CareJourney, says this push for alternative payment models will lead not only to a reduction in unnecessary expenditures but also higher preventive service utilization and more primary care visits.
-
Surescripts webinar highlights: Interoperability progress depends on how you look at it
Register to view a webinar, sponsored by Surescripts, highlighting progress made on interoperability and what’s needed to improve and expand it.
-
Consumer / Employer, Policy, SYN
How the test-to-treat pillar of the U.S. Covid strategy is failing patients
Large swaths of the country had no test-to-treat pharmacies or health centers listed as of April 14. And the website of the largest participant, CVS, has significant technical issues that make booking an appointment difficult.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
